DE2402221A1 - PROCESS FOR THE PRODUCTION OF HESPERETINE DIHYDROCHALCONGLUCOSIDE - Google Patents
PROCESS FOR THE PRODUCTION OF HESPERETINE DIHYDROCHALCONGLUCOSIDEInfo
- Publication number
- DE2402221A1 DE2402221A1 DE2402221A DE2402221A DE2402221A1 DE 2402221 A1 DE2402221 A1 DE 2402221A1 DE 2402221 A DE2402221 A DE 2402221A DE 2402221 A DE2402221 A DE 2402221A DE 2402221 A1 DE2402221 A1 DE 2402221A1
- Authority
- DE
- Germany
- Prior art keywords
- enzyme
- carrier
- activity
- dihydrochalcone
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 11
- AIONOLUJZLIMTK-UHFFFAOYSA-N 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one Chemical compound C1=C(O)C(OC)=CC=C1C1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-UHFFFAOYSA-N 0.000 title claims description 4
- 238000004519 manufacturing process Methods 0.000 title description 4
- 108090000790 Enzymes Proteins 0.000 claims description 30
- 102000004190 Enzymes Human genes 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 16
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 13
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 13
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 13
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 11
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 11
- 108010030923 hesperidinase Proteins 0.000 claims description 11
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 10
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 10
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 10
- 229940025878 hesperidin Drugs 0.000 claims description 10
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 10
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 7
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 7
- 239000005373 porous glass Substances 0.000 claims description 6
- 150000004984 aromatic diamines Chemical class 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000002414 glycolytic effect Effects 0.000 claims description 3
- AIONOLUJZLIMTK-AWEZNQCLSA-N hesperetin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 AIONOLUJZLIMTK-AWEZNQCLSA-N 0.000 claims description 3
- 229960001587 hesperetin Drugs 0.000 claims description 3
- 235000010209 hesperetin Nutrition 0.000 claims description 3
- FTODBIPDTXRIGS-UHFFFAOYSA-N homoeriodictyol Natural products C1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 FTODBIPDTXRIGS-UHFFFAOYSA-N 0.000 claims description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 26
- 239000000243 solution Substances 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 10
- 229930182478 glucoside Natural products 0.000 description 10
- -1 hesperetin dihydrochalcone glucoside Chemical class 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000007979 citrate buffer Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000012876 carrier material Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 2
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 108010001078 naringinase Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KOGDFDWINXIWHI-OWOJBTEDSA-N 4-[(e)-2-(4-aminophenyl)ethenyl]aniline Chemical compound C1=CC(N)=CC=C1\C=C\C1=CC=C(N)C=C1 KOGDFDWINXIWHI-OWOJBTEDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/096—Polyesters; Polyamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
- C12N11/12—Cellulose or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Seasonings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
L. Givaudan & Qe Societe Anonyme, Vernier-Geneve (Schweiz)L. Givaudan & Qe Societe Anonyme, Vernier-Geneve (Switzerland)
Es ist bekannt, dass das geschmacklose G-lykosid Hesperidin, das vor allem in den Schalen von Citrusfrüchten vorkommt, durch Behandlung mit Alkali, Hydrierung und enzymatisch^ Hjrdrolyse in das sehr süsse und daher als Süsstoff verwendbare Hesperetindihydrochalkonglucosid der FormelIt is known that the tasteless G-lycoside hesperidin, which occurs mainly in the peel of citrus fruits, by treatment with alkali, hydrogenation and enzymatic hydrolysis into the very sweet hesperetin dihydrochalcone glucoside, which can therefore be used as a sweetener the formula
CH2OHCH 2 OH
übergeführt werden kann (siehe z.B. U.S.Pat. No. 3 583 894). Dabei wird das Hesperidindihydrochalkon der Formelcan be transferred (see e.g. U.S. Pat. No. 3,583,894). The hesperidine dihydrochalcone is of the formula
Jrn/5.11.73Jrn / 11/5/73
409835/1019409835/1019
OHOH
OHOH
IIII
der Einwirkung des Enzymsystems Naringinase unterworfen, dessen. ß-Glucosidaseaktivität weitgehend zerstört wurde, so dass es überwiegend nur noch die Ehamnose abspaltet. Die Inaktivierung der ß-Glucosidase des Enzymsystems erfolgt dabei durch Erhitzen einer wässrigen Naringinasesuspension auf eine Temperatur von etwa 60 - 650C während 30 - 120 Minuten, bei einem pH-Wert von 6,4 - 6,8. Diese Methode ist jedoch mit einem teilweisen Verlust an Bhamnosidaseaktivität verbunden, dessen absolute Grosse nicht reproduzierbar ist.subjected to the action of the enzyme system naringinase, its. ß-glucosidase activity was largely destroyed, so that it mainly only splits off the ehamnosis. The inactivation of the beta-glucosidase enzyme of the system is effected by heating an aqueous Naringinasesuspension to a temperature of about 60-65 0 C for 30-120 minutes, at a pH from 6.4 to 6.8. However, this method is associated with a partial loss of bhamnosidase activity, the absolute value of which cannot be reproduced.
Es ist nun überraschenderweise gefunden worden, dass bei Fixierung eines glykolytischen Enzyms bzw. Enzymsystems mit Rhamnosidaseaktivität, wie es beispielsweise die ITaringinase und Hesperidinase darstellen, an einen Träger, insbesondere an einen festen aktivierten Träger, die ß-Glucosidaseaktivität selektiv gehemmt wird.It has now surprisingly been found that when a glycolytic enzyme or enzyme system is fixed with Rhamnosidase activity, such as ITaringinase and represent hesperidinase, on a carrier, in particular on a solid activated carrier, the β-glucosidase activity is selectively inhibited.
Die vorliegende Erfindung betrifft demgemäss ein Verfahren zur Herstellung von Hesperetindihydrochalkonglucosid aus Hesperidindihydrochalkon mittels glykolytischer Enzyme oder Enzymsysteme mit Rhamnosidaseaktivität, wie sie die Hesperidinase und Naringinase darstellen, welches Verfahren dadurch gekennzeichnet ist, dass man ein trägergebundenes Enzym oder Enzymsystem mit inhibierter ß-Glucosidaseaktivität verwendet.The present invention accordingly relates to a process for the production of hesperetin dihydrochalcone glucoside from hesperidin dihydrochalcone using glycolytic enzymes or enzyme systems with rhamnosidase activity, as represented by hesperidinase and naringinase, which process thereby is characterized in that a carrier-bound enzyme or enzyme system with inhibited ß-glucosidase activity is used.
409835/1019409835/1019
Die Erfindung betrifft ferner ein glykolytisch.es Enzym- bzw. Enzymsystemderivat mit Rhamnoaidaseaktivität und inhibierter ß-Glucosidaseaktivität, das durch Kopplung des Enzyms bzw. Enzymsystems an ein festes Trägermaterial die ß-Glucosidaseaktivität, insbesondere in Bezug auf Hesperidindihydrochalkon als Substrat,weitgehend verloren hat, sowie dessen Herstellung und Verwendung zur Ueberführung von Hesperidindihydrochalkon in Hesperetindihydrochalkonglucosid.The invention also relates to a glycolytisch.es enzyme or enzyme system derivative with rhamnoaidase activity and inhibited ß-glucosidase activity, which by coupling the enzyme or Enzyme system to a solid carrier material the ß-glucosidase activity, in particular with regard to hesperidine dihydrochalcone as substrate, has largely lost, as well as its production and use for converting hesperidin dihydrochalcone into hesperetin dihydrochalcone glucoside.
Ein im Zusammenhang mit der vorliegenden Erfindung bevorzugtes Enzym bzw. Enzymsystem ist die Hesperidinase, ein im Handel erhältliches Produkt.An enzyme or enzyme system preferred in connection with the present invention is hesperidinase, a commercially available product.
Als feste Trägermaterialien, die sich für die Herstellung erfindungsgeroässer Enzympräparate,insbesondere von Hesperidinase mit inhibierter ß-Glueosidaseaktivität eignen, sind Polymere auf organischer und anorganischer Basis zu nennen. Als anorganische Materialien kommen natürliche und synthetische Silikate und silikathaltige Substanzen,wie z.B. Glas, Sand, SiIicagel, Kieselgur, Bentonit, Wollastonit aber auch Metalloxide wie Aluminiumoxid und Hydroxylapatit in Frage. Beispiele geeigneter Polymerer auf organischer Basis sind Cellulose und Polyamide. In einer besonders bevorzugten Ausführungsform der vorliegenden Erfindung kann mit porösem Glas als Trägermaterial gearbeitet werden, wie es z.B. im Handel erhältlich ist, vorzugsweise mit einer Partikelgrösse von etwa 80 - 400 mesh und einem durchschnittlichen Porendurchmesser von etwa • 75 - 2000 1. Das Trägermaterial kann jedoch, wenn die Verhältnisse es erfordern, auch andere Form und/oder Grb'sse haben.As solid support materials that can be used for manufacturing Enzyme preparations according to the invention, in particular hesperidinase Polymers with inhibited β-glueosidase activity are suitable on an organic and inorganic basis. As inorganic Materials come from natural and synthetic silicates and substances containing silicate, such as glass, sand, silicon gel, Diatomaceous earth, bentonite, wollastonite but also metal oxides such as aluminum oxide and hydroxyapatite are possible. Examples of suitable ones Organic-based polymers are cellulose and polyamides. In a particularly preferred embodiment In the present invention, porous glass can be used as the support material, such as is commercially available is, preferably with a particle size of about 80-400 mesh and an average pore diameter of about • 75 - 2000 1. The carrier material can, however, if the proportions require it to have a different shape and / or sizes.
Das feste Trägermaterial wird zweckmässigerweise mit einer Schicht eines aromatischen Diamins überzogen, was vorteilhafterweise durch Behandlung mit einer Lösung des Amins, ge-The solid support material is expediently with a Layer of an aromatic diamine coated, which is advantageous by treatment with a solution of the amine,
40.9 835/101940.9 835/1019
gebenenfalls unter leichtem Erwärmen, erfolgen kann. Als aromatische Diamine eignen sich beispielsweise 1,3-Phenylendiamin, 4,4l-Diamino-diphenyl, 4,4'-Diaminostilben oder 4,4'-Diamino-if necessary with slight warming, can be done. As the aromatic diamines, for example, 4,4'-diaminostilbene or 4,4'-diamino are 1,3-phenylenediamine, 4,4-diamino-l diphenyl
diphenyl-methan sowie· entsprechende substituierte Verbindungen. Ein besonders bevorzugtes Diamin ist das 4,4'-Diamirio-diphenylmethan. Dann diazotiert man das so erhaltene Produkt in an sich bekannter Weise, z.B. durch Umsetzung mit Nitrit und Säure, wie Salzsäure oder Essigsäure, zweckmässig bei Temperaturen zwischen 0° und Zimmertemperatur. Durch das vorstehend beschriebene Verfahren erhalten die Trägerpartikel einen fest haftenden Ueberzug, der für die Fixierung des Proteins aktiviert ist.diphenyl methane and · corresponding substituted compounds. A particularly preferred diamine is 4,4'-diamirio-diphenylmethane. The product obtained in this way is then diazotized in a manner known per se, e.g. by reaction with nitrite and acid, such as hydrochloric acid or acetic acid, expediently at temperatures between 0 ° and room temperature. Through the above described In the process, the carrier particles are given a firmly adhering coating that is used to fix the protein is activated.
Zur Fixierung des Enzyms an den aktivierten festen Träger behandelt man diesen mit einer Lösung des Enzyms, wobei zweckmässigerweise ein Verhältnis Protein/Träger von 1-50 mg/g eingehalten werden sollte. Als lösungsmittel für das Enzym kommen alle dem Fachmann geläufigen in Frage, insbesondere Pufferlösungen, z.B. Phosphat-oder Citratpuffer. Die Umsetzung des Enzyms mit dem diazotierten Trägermaterial erfolgt vorzugsweise in einer Pufferlösung mit einem pH-Wert zwischen etwa 4,5 und 8,0 unter Schütteln von etwa 30 Minuten bis zu 24 Stunden, vorzugsweise von 1-2 Stunden, und bei einer Temperatur zwischen 0° und 300C. Besonders bevorzugt im Fall der Verwendung von Hesperidinase ist ein Puffer vom pH-Wert 6,0 bis 7,5 und eine Eeaktionstemperatur von ca. 40C.In order to fix the enzyme to the activated solid carrier, it is treated with a solution of the enzyme, a protein / carrier ratio of 1-50 mg / g should expediently be maintained. Suitable solvents for the enzyme are all those familiar to the person skilled in the art, in particular buffer solutions, for example phosphate or citrate buffers. The reaction of the enzyme with the diazotized carrier material is preferably carried out in a buffer solution with a pH between about 4.5 and 8.0 with shaking from about 30 minutes to 24 hours, preferably from 1-2 hours, and at a temperature between 0 ° and 30 0 C. particularly preferred in the case of using hesperidinase is a buffer of pH 6.0 to 7.5 and a Eeaktionstemperatur of about 4 0 C.
Das so erhaltene, an einen festen aktivierten Träger gebundene Enzym, dessen ß-G-lucosidaseaktivität selektiv inhibiert ist, eignet sich zum Abbau von Hesperidindihydrochalkon zu Hesperetindihydrochalkonglucosid. Darüber hinaus besitzt das so erhaltene insolubilisierte Enzym die bekannten vorteil-The enzyme thus obtained, bound to a solid activated carrier, selectively inhibits its β-G-lucosidase activity is suitable for the degradation of hesperidin dihydrochalcone to hesperetin dihydrochalcone glucoside. In addition, owns the insolubilized enzyme obtained in this way has the known advantageous
409835/1019409835/1019
haften Eigenschaften: es lässt sich leicht vom Substrat abtrennen, beispielsweise durch Filtration oder Zentrifugieren, kann mehrfach gebraucht werden'und eignet sich besonders für eine kontinuierliche Prozessführung. Schliesslich weist das ' erfindungsgemäss erhaltene Enzympräparat eine hohe Stabilität auf. Für an poröses Glas gebundene Hesperidinase wurde eine besonders gute Aktivität und Stabilität bei kontinuierlicher Reaktionsführung in Säulen, wie sie beispielsweise aus der Chromatographie bekannt ist, beobachtet.Adhesive properties: it can be easily separated from the substrate, for example by filtration or centrifugation, can be used several times and is particularly suitable for continuous litigation. Finally, the enzyme preparation obtained according to the invention has a high stability. For hesperidinase bound to porous glass, a particularly good activity and stability was found at continuous reaction in columns, as it is known, for example, from chromatography, observed.
Die Umsetzung des Hesperidindihydrochalkons mit dem trägergebundenen Enzym kann in an sich bekannter Weise erfolgen und zwar sowohl in stationärem Betrieb, z.B. in Rührreaktoren, oder, wie bereits erwähnt, mit Vorteil in kontinuierlichem Betrieb, beispielsweise in Reaktionssäulen. Man geht dabei von lösungen mit einer Substratkonzentration von etwa 5?° aus, jedoch können selbstverständlich auch höher oder niedriger konzentrierte Lösungen eingesetzt werden. Die Aufarbeitung des Reaktionsproduktes ist problemlos und kann in bekannter Weise erfolgen« Sie kann beispielsweise lediglich in einem Einengen zur Trockene ohne weitere Reinigung bestehen, da das bei der Spaltung gegebenenfalls in geringen Mengen als Nebenprodukt anfallende Aglykon ebenfalls süss und physiologisch unbedenklich ist.The Hesperidin dihydrochalkons can be reacted with the carrier-bound enzyme in a manner known per se, both in stationary operation, for example in stirred reactors, or, as already mentioned, advantageously in continuous operation, for example in reaction columns. Solutions with a substrate concentration of about 5 ° are assumed, but solutions with a higher or lower concentration can of course also be used. The reaction product can be worked up without any problems and can be carried out in a known manner. For example, it can only consist of concentration to dryness without further purification, since the aglycone which may be obtained in small amounts as a by-product during the cleavage is also sweet and physiologically harmless.
Die folgenden Beispiele erläutern die Erfindung:The following examples illustrate the invention:
409835/1019409835/1019
Beispiel 1 Herstellung des aktivierten Trägersexample 1 Preparation of the activated carrier
1 g poröses Glas (120-200 mesh, Porendurchmesser: 2000 A) wurde zu einer Lösung von 200 mg 4>4'-Diaminodiphenylmethan in 10 ml trockenem Benzol gegeben. Das Gemisch wurde 5 Minuten unter gelegentlichem Schütteln auf dem Wasserbad (80°) erwärmt, sodann abgenutscht, bis alles Benzol entfernt war. Der Rückstand wurde in 20 ml eiskaltes Wasser gegebe-n, unter Rühren mit 300 mg Natriumnitrit und sodann mit verdünnter Salzsäure (20 Vol-fo) versetzt, bis zu einem pH-Wert von 1-2. Danach wurde 10 Minuten bei 0° gerührt, der pH-Wert durch .Zusatz von 1 N Natronlauge auf 5 eingestellt und der Ueberstand abdekantiert. Der Rückstand wurde mehrmals mit eiskaltem Wasser, das durch Zusatz von Salzsäure auf pH 4-5 gebracht worden war, gewaschen, bis der Ueberstand farblos war. Die so erhaltenen Partikel wurden unmittelbar für die Enzymfixierung verwendet.1 g of porous glass (120-200 mesh, pore diameter: 2000 Å) was added to a solution of 200 mg of 4>4'-diaminodiphenylmethane in 10 ml of dry benzene. The mixture was heated on the water bath (80 °) for 5 minutes with occasional shaking, then suction filtered until all of the benzene was removed. The residue was poured into 20 ml of ice-cold water, 300 mg of sodium nitrite and then dilute hydrochloric acid (20 vol-fo) were added while stirring, up to a pH of 1-2. The mixture was then stirred for 10 minutes at 0 °, the pH was adjusted to 5 by adding 1N sodium hydroxide solution and the supernatant was decanted off. The residue was washed several times with ice-cold water, which had been brought to pH 4-5 by adding hydrochloric acid, until the supernatant was colorless. The particles thus obtained were used directly for the enzyme fixation.
1 g des gemäss Beispiel 1 hergestellten Trägermaterials wurde zu 25 ml einer eiskalten Lösung von 2 mg Hesperidinase (5,2 Einheiten/mg) in 0,05 M Phosphatpuffer (pH 6,5-7,8) gegeben und bei 4° 1 Stunde leicht geschüttelt. Danach wurde filtriert, die Partikel wurden dreimal mit je 50 ml 1 M Kaliumchloridlösung und einmal mit 50 ml 0,05 M Citratpuffer (pH 6,5) gewaschen, in 50 ml 0,05 M Citratpuffer pH 6,5 suspendiert und dann bei 4° aufbewahrt.1 g of the carrier material prepared according to Example 1 was added to 25 ml of an ice cold solution of 2 mg hesperidinase (5.2 units / mg) in 0.05 M phosphate buffer (pH 6.5-7.8) and shaken gently at 4 ° for 1 hour. It was then filtered, and the particles were washed three times with 50 ml of 1 M potassium chloride solution each time and washed once with 50 ml of 0.05 M citrate buffer (pH 6.5), suspended in 50 ml of 0.05 M citrate buffer pH 6.5 and then stored at 4 °.
409835/ 1019409835/1019
Ueberführunig; von Hesperidindihydrochalkon in Hesperetindihyd.rochalkongluc ο s idTransferable; of hesperidindihydrochalkon in hesperetindihyd.rochalkongluc ο s id
2 g von gemäss Beispiel 2 erhaltener, an poröses Glas gebundener Hesperidinase (4,3 Einheiten) wurden mit einer Lösung von 500 mg Hesperidindihydrochalkon in 20 ml 0,05'M Citratpuffer (pH 4,5) 2 Stunden lang bei 45° geschüttelt. Chromatographische Analyse der Reaktionslösung zeigte, dass nach dieser Zeit das Hesperidindihydrochalkon quantitativ in Hesperetindihydrochalkonglucosid umgewandelt worden war, wobei Spuren des entsprechenden Aglykons nachgewiesen werden konnten. Das trägergebundene Enzym wurde abfiltriert, mit. 0,05 M Citratpuffer (pH 6,5) bei 45° gewaschen und sofort wieder verwendet bzw. bei 4° für die erneute Verwendung aufbewahrt. Das Piltrat wurde mit den Waschlösungen vereinigt und unter vermindertem Druck zur Trockene eingeengt. Der Rückstand wurde dreimal mit 50 ml Dioxan extrahiert. Nach Abziehen des Lösungsmitte 3s lieferte der Extrakt 240 mg (Ausbeute lOfo) des sehr süssen Hesperetindihydrochalkonglucösids.2 g of hesperidinase (4.3 units) obtained according to Example 2 and bound to porous glass were shaken at 45 ° for 2 hours with a solution of 500 mg hesperidin dihydrochalcone in 20 ml 0.05'M citrate buffer (pH 4.5). Chromatographic analysis of the reaction solution showed that after this time the hesperidin dihydrochalcone had been converted quantitatively into hesperetin dihydrochalcone glucoside, traces of the corresponding aglycone being detected. The carrier-bound enzyme was filtered off with. 0.05 M citrate buffer (pH 6.5) washed at 45 ° and used again immediately or stored at 4 ° for renewed use. The piltrate was combined with the wash solutions and concentrated to dryness under reduced pressure. The residue was extracted three times with 50 ml of dioxane. After removing the solvent for 3 seconds, the extract gave 240 mg (yield 10fo) of the very sweet hesperetin dihydrochalcone glucoside.
Eine gleich gute Ausbeute an G-lucosid wurde durch dreimalige direkte Extraktion der Reaktionslösung mit Aethylacetat ohne vorheriges Einengen erhalten.An equally good yield of G-lucoside was obtained three times direct extraction of the reaction solution with ethyl acetate obtained without prior constriction.
Durch Kühlung der Reaktionslösung mit Eis wird eine kristalline Ausscheidung des G-lucosids erreicht. Diese Aufarbeitung ist zwar nicht quantitativ, eignet sich aber bei grösseren Ansätzen gut, wo Extraktionsmethoden weniger geeignet sind.By cooling the reaction solution with ice, a crystalline excretion of the glucoside is achieved. This work-up is not quantitative, but is well suited for larger batches where extraction methods are less suitable are.
409835/1019409835/1019
Ueberführung von Hesperidindihydrochalkon. in HesperetindihydrochalkODfflucosidConversion of hesperidinedihydrochalcone. in hesperetin dihydrochalkODfflucoside
3 g von.:gemäss Beispiel 2 erhaltener, an poröses Glas gebundener Hesperidinase (8,1 Einheiten) wurden in einer Glassäule (1,0 χ 10 cm) mit einer Lösung von 50 mg Hesperidindihydrochalkon in 0,05 M Citratpu'ffer (pH 4,5) bei 45° behandelt, wobei eine Durchflussrate von 11 ml/h eingehalten wurde. Kontinuierliche chromatographische Analyse zeigte den quantitativen Abbau des Hesperidindihydrochalkons zu Hesperetindihydrochalfconglucosid und Rhamnose sowie eine Spur des Aglykone an.3 g of hesperidinase (8.1 units) obtained according to Example 2 and bound to porous glass were placed in a glass column (1.0 χ 10 cm) with a solution of 50 mg hesperidin dihydrochalcone in 0.05 M citrate buffer (pH 4.5) at 45 °, with a flow rate of 11 ml / h was maintained. Continuous chromatographic analysis showed the quantitative degradation of hesperidin dihydrochalcone to form hesperetin dihydrochalconium glucoside and rhamnose as well as a trace of aglycones.
Ueberführung von Hesperidindihydrochalkon in HesperetindihydrochalkonglucosidConversion of hesperidine dihydrochalcone into hesperetin dihydrochalcone glucoside
In einer Reaktionssäule, die 5 g trägergebundene Hesperidinase (20 mg Enzym) enthielt, wurden in kontinuierlichem Betrieb über 2 Wochen bei einer anfänglichen Durchflussrate von 20 ml/h, die gegen Ende der Betriebsdauer auf 10 ml/h zurückging, 118 g Hesperidindihydrochalkon quantitativ hydrolysiert, ohne dass die Aktivität des Enzyms erschöpft gewesen wäre.In a reaction column which contained 5 g of carrier-bound hesperidinase (20 mg of enzyme) were in continuous operation over 2 weeks at an initial flow rate of 20 ml / h, which decreased to 10 ml / h towards the end of the operating time, 118 g of hesperidinedihydrochalcone hydrolyzed quantitatively without the enzyme's activity being exhausted.
409835/1019409835/1019
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH260273A CH579098A5 (en) | 1973-02-22 | 1973-02-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2402221A1 true DE2402221A1 (en) | 1974-08-29 |
Family
ID=4237445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2402221A Pending DE2402221A1 (en) | 1973-02-22 | 1974-01-17 | PROCESS FOR THE PRODUCTION OF HESPERETINE DIHYDROCHALCONGLUCOSIDE |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS49116295A (en) |
CH (1) | CH579098A5 (en) |
DE (1) | DE2402221A1 (en) |
ES (1) | ES423449A1 (en) |
FR (1) | FR2228069B1 (en) |
GB (1) | GB1404306A (en) |
IL (1) | IL43784A (en) |
NL (1) | NL7400180A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819520A (en) * | 2014-02-14 | 2014-05-28 | 闻永举 | Method for preparing mono-glucoside through selective hydrolysis of flavone rutinoside or neohesperidoside |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108220366A (en) * | 2018-01-23 | 2018-06-29 | 山东奔月生物科技有限公司 | Hesperetin dihydrochalcone -7-O- glucoside bioanalysis synthesis technologies |
CN110200256A (en) * | 2019-06-28 | 2019-09-06 | 山东奔月生物科技股份有限公司 | The preparation method of new-type compound sweetener |
CN110551011A (en) * | 2019-09-26 | 2019-12-10 | 陕西嘉禾生物科技股份有限公司 | synthesis method of hesperetin dihydrochalcone |
CN113881659B (en) * | 2021-09-24 | 2024-02-20 | 华南理工大学 | Method for preparing hesperetin dihydrochalcone glucoside by immobilized enzyme method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH579533A5 (en) * | 1972-07-12 | 1976-09-15 | Givaudan & Cie Sa |
-
1973
- 1973-02-22 CH CH260273A patent/CH579098A5/xx not_active IP Right Cessation
- 1973-12-10 IL IL43784A patent/IL43784A/en unknown
-
1974
- 1974-01-07 NL NL7400180A patent/NL7400180A/xx unknown
- 1974-01-17 DE DE2402221A patent/DE2402221A1/en active Pending
- 1974-02-14 JP JP49018095A patent/JPS49116295A/ja active Pending
- 1974-02-20 FR FR7405744A patent/FR2228069B1/fr not_active Expired
- 1974-02-21 ES ES423449A patent/ES423449A1/en not_active Expired
- 1974-02-21 GB GB793374A patent/GB1404306A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819520A (en) * | 2014-02-14 | 2014-05-28 | 闻永举 | Method for preparing mono-glucoside through selective hydrolysis of flavone rutinoside or neohesperidoside |
Also Published As
Publication number | Publication date |
---|---|
GB1404306A (en) | 1975-08-28 |
IL43784A (en) | 1977-04-29 |
FR2228069A1 (en) | 1974-11-29 |
CH579098A5 (en) | 1976-08-31 |
NL7400180A (en) | 1974-08-26 |
JPS49116295A (en) | 1974-11-06 |
ES423449A1 (en) | 1976-05-16 |
FR2228069B1 (en) | 1978-03-24 |
IL43784A0 (en) | 1974-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004006367C5 (en) | Polymorphic form of rifaximin as an antibiotic | |
DE2526594C2 (en) | Process for the production of L-phenylglycine and for the recovery of D-phenylglycine amide | |
DE1792773C3 (en) | Tubular shaped body made of an insoluble carrier, which is permeable or impermeable, with an enzyme chemically bound to the carrier via a bridging residue | |
DE1695850A1 (en) | Process for the isolation and purification of soluble ribonucleic acid | |
DE4307422B4 (en) | Process for the preparation of clavulanic acid salts | |
DE2716533C3 (en) | N-acetylated or -haloacetylated kanamycins A and B, process for their preparation and their use | |
DE2402221A1 (en) | PROCESS FOR THE PRODUCTION OF HESPERETINE DIHYDROCHALCONGLUCOSIDE | |
DE102005025560A1 (en) | Process for the purification of betaines | |
JPH01104089A (en) | Bifunctional oligosaccharides and active compounds derived therefrom | |
CH626368A5 (en) | Process for the preparation of 6-D-(-)-alpha-amino- alpha-(p-hydroxyphenyl)acetamidopenicillanic acid | |
DE2514185A1 (en) | HALOGENATED ANTIBIOTICS AND METHOD FOR MANUFACTURING THEREOF | |
CH589667A5 (en) | Hesperetin dihydrochalcone glucoside sweetener prepn. - by hesperidin dihydrochalcone degradation using carrier-bonded glycolytic enzyme system | |
CN109293722A (en) | Related substance of a kind of azithromycin and preparation method thereof | |
DE1795523A1 (en) | Tetrahydropyranyl derivatives of N-carboxy or N-thiocarboxy anhydrides of aromatic hydroxy-alpha-amino acids and process for their preparation | |
EP3516067B1 (en) | Compound and chewing gum including the compound for detection of viruses by taste | |
EP0257418B1 (en) | Oxirane-pseudo-oligosaccharides, process for their synthesis, their use and pharmaceutical preparations | |
DE3205169A1 (en) | NEW ERGOL DERIVATIVES, THEIR PRODUCTION AND THEIR PHARMACEUTICAL COMPOSITIONS | |
AT343799B (en) | METHOD OF PREPARING ANTIBACTERIAL COMPOUNDS | |
DE2223535C3 (en) | Hydrochloride of the copper complex of bleomycinic acid and its production | |
DE2809629C2 (en) | Process for the preparation of 2-bromo-3-cyano-4,6-diaminopyridine hydrobromide | |
DE2102988A1 (en) | New peptide, its manufacture and compositions containing it | |
AT380258B (en) | METHOD FOR PRODUCING SODIUM AMPICILLIN | |
CH556879A (en) | Purification of antibiotic amphotericin B - by salt formation in aq. dimethylformamide, pptn. and washing | |
AT389516B (en) | Novel oxirane-pseudooligosaccharides, process for their preparation, their use and pharmaceutical products containing them | |
TWI396690B (en) | Process for preparing camptothecin analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHJ | Non-payment of the annual fee |